Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,368 | 1,027 | 99.8% |
| Education | $29.20 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,609 | 152 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,884 | 146 | $0 (2023) |
| PFIZER INC. | $1,665 | 146 | $0 (2024) |
| Lilly USA, LLC | $1,231 | 87 | $0 (2024) |
| Novo Nordisk Inc | $697.16 | 49 | $0 (2024) |
| Allergan, Inc. | $678.68 | 68 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $606.12 | 47 | $0 (2022) |
| GlaxoSmithKline, LLC. | $558.58 | 37 | $0 (2024) |
| Amgen Inc. | $554.67 | 40 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $451.66 | 34 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,247 | 63 | AstraZeneca Pharmaceuticals LP ($330.13) |
| 2023 | $1,599 | 103 | AstraZeneca Pharmaceuticals LP ($286.77) |
| 2022 | $1,775 | 116 | Boehringer Ingelheim Pharmaceuticals, Inc. ($326.52) |
| 2021 | $2,108 | 151 | Boehringer Ingelheim Pharmaceuticals, Inc. ($403.01) |
| 2020 | $1,811 | 132 | AstraZeneca Pharmaceuticals LP ($303.66) |
| 2019 | $2,116 | 167 | AstraZeneca Pharmaceuticals LP ($362.20) |
| 2018 | $1,540 | 123 | AstraZeneca Pharmaceuticals LP ($345.30) |
| 2017 | $2,202 | 177 | AstraZeneca Pharmaceuticals LP ($440.62) |
All Payment Transactions
1,032 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Diabetes Care | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Respiratory | ||||||
| 12/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Diabetes Care | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Diabetes Care | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Cardio-renal | ||||||
| 10/07/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Diabetes Care | ||||||
| 10/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: VACCINES | ||||||
| 09/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: VACCINES | ||||||
| 09/09/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Genetic Disease | ||||||
| 09/05/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Diabetes Care | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Respiratory | ||||||
| 08/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $43.13 | General |
| Category: Endocrinology | ||||||
| 08/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: Diabetes | ||||||
| 08/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: RESPIRATORY | ||||||
| 08/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Respiratory | ||||||
| 07/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Genetic Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,646 | 2,159 | $234,905 | $71,836 |
| 2022 | 26 | 1,600 | 2,134 | $216,781 | $71,899 |
| 2021 | 26 | 1,611 | 2,131 | $183,405 | $75,347 |
| 2020 | 30 | 1,964 | 2,689 | $222,462 | $78,751 |
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 170 | 277 | $72,143 | $20,299 | 28.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 161 | 161 | $43,470 | $19,383 | 44.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 55 | $19,586 | $5,820 | 29.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 102 | $17,616 | $4,738 | 26.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 44 | 44 | $3,711 | $3,306 | 89.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 137 | 184 | $11,923 | $2,414 | 20.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 157 | 271 | $3,902 | $2,276 | 58.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 71 | 77 | $10,996 | $2,234 | 20.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 133 | 176 | $8,870 | $1,822 | 20.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 45 | 45 | $1,478 | $1,347 | 91.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 122 | 142 | $5,282 | $1,081 | 20.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 63 | 99 | $4,633 | $942.48 | 20.3% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 42 | 42 | $3,730 | $794.64 | 21.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 30 | 46 | $3,698 | $757.16 | 20.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,220 | $622.55 | 14.8% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 32 | 46 | $3,036 | $614.56 | 20.2% |
| 83550 | Iron binding capacity | Office | 2023 | 30 | 44 | $1,848 | $377.08 | 20.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $1,156 | $374.40 | 32.4% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 24 | 40 | $1,728 | $353.60 | 20.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 21 | 22 | $1,610 | $325.16 | 20.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 13 | 13 | $2,496 | $322.79 | 12.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 18 | 18 | $1,178 | $291.06 | 24.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 29 | 34 | $1,387 | $281.86 | 20.3% |
| 83540 | Iron level | Office | 2023 | 30 | 44 | $1,373 | $278.96 | 20.3% |
| 84460 | Liver enzyme (sgpt), level | Office | 2023 | 38 | 50 | $1,260 | $259.50 | 20.6% |
About Dr. Richard Shimizu, MD
Dr. Richard Shimizu, MD is a Internal Medicine healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164466645.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Shimizu, MD has received a total of $14,397 in payments from pharmaceutical and medical device companies, with $1,247 received in 2024. These payments were reported across 1,032 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($14,368).
As a Medicare-enrolled provider, Shimizu has provided services to 6,821 Medicare beneficiaries, totaling 9,113 services with total Medicare billing of $297,833. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Springfield, MO
- Active Since 06/15/2006
- Last Updated 07/05/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1164466645
Products in Payments
- FARXIGA (Drug) $1,803
- JARDIANCE (Drug) $1,380
- ELIQUIS (Drug) $785.51
- TRULICITY (Drug) $710.86
- CHANTIX (Drug) $649.67
- XARELTO (Drug) $501.37
- FREESTYLE LIBRE (Device) $425.23
- Livalo (Drug) $409.73
- SHINGRIX (Biological) $390.29
- SPIRIVA RESPIMAT (Drug) $384.77
- Ozempic (Drug) $315.89
- MOUNJARO (Drug) $314.23
- BEVESPI AEROSPHERE (Drug) $295.71
- JANUVIA (Drug) $275.49
- FABRAZYME (Biological) $213.41
- LINZESS (Drug) $210.19
- Prolia (Biological) $187.61
- INJECTAFER (Drug) $181.47
- ENTRESTO (Drug) $173.36
- NURTEC ODT (Drug) $173.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Springfield
Dr. Steven Gradney, M.d, M.D
Internal Medicine — Payments: $568,658
Dr. James Bonucchi, Do, DO
Internal Medicine — Payments: $304,681
John Flack, Md, Mph, MD, MPH
Internal Medicine — Payments: $125,897
Dr. Sudeshna Banerjee, Md, MD
Internal Medicine — Payments: $62,767
Dr. Paul Madaj, M.d, M.D
Internal Medicine — Payments: $58,030
Dr. Indrajeet Mahata, M.d, M.D
Internal Medicine — Payments: $47,372